To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
743.00+6.14% from last year
Operating profits
79.00+261.22% from last year
Net income
-45.00+74.58% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2008
Net worth4352.003359.003354.003849.003376.002671.672674.802852.153336.713775.123715.353581.472704.181471.02943.101017.73
Fixed assets2736.002881.003042.003462.003343.003502.293057.932887.962772.552808.702122.742294.631989.602571.342580.222996.17
Debt1859.002112.001887.001862.002332.003213.233374.603747.824159.752676.602010.071906.082070.473492.503851.664235.12
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011
Operating-22.00219.00153.00413.00-287.00648.96183.3268.44-269.4771.61354.961476.291532.401343.83641.81
Investing -783.00-137.00-125.00-201.001470.00-155.5394.57630.24-686.64-818.19-206.63-851.621085.37-305.45-276.61
Financing 409.00334.00-315.00-71.00-1171.00-679.58-776.45-769.471254.49254.26-75.65-601.32-2245.75-826.56-372.99

Financial ratios

Profitability ratiosinfo2
ROA-0.78%
ROE-1.48%
ROCE4.07%
EPS-2.9%
Net profit margin-1.89%
Operating profit margin11.77%
Dividend per share
Operational ratiosinfo2
Quick ratio0.85%
Current ratio1.21%
Interest coverage0.94%
Assets turnover0.53%
Debt to equity0.43%
Valuation ratiosinfo2
P/E ratio
P/B ratio5.53%
Dividend yield
EV/EBITDA
Wockhardt Limited is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. The company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.
personal

Grow your wealth with more research recommendations

+91